CLRBW
Cellectar Biosciences Inc
Halal Rating :
Last Price
$0.00
Last updated:
Market Cap
-
7D Change
0.0%
1 Year Change
0.0%
Company Overview
Industries
Exchange
Next Earnings Date
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's primary focus is on developing innovative small molecule drug conjugates (SMDCs) specifically designed to target and deliver therapeutic payloads to cancer cells.
The company's lead product candidate is iopofosine I-131, a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Cellectar Biosciences Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.